PKM and cancer: Although TEPP-46 can enhance PKM2 activity, leading to reduced lactate production and lipid synthesis, treatment with TEPP-46 alone does not induce cytotoxic changes and it is likely that cancer cells persist in a quiescent state, which has been linked to treatment resistance and disease recurrence.